Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2018 Jul 16;12(7):e0006583.
doi: 10.1371/journal.pntd.0006583. eCollection 2018 Jul.

Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016

Affiliations
Comparative Study

Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016

Meru Sheel et al. PLoS Negl Trop Dis. .

Abstract

Introduction: Under the Global Programme to Eliminate Lymphatic Filariasis (LF), American Samoa conducted seven rounds of mass drug administration (MDA) from 2000-2006. The World Health Organization recommends systematic post-MDA surveillance using Transmission Assessment Surveys (TAS) for epidemiological assessment of recent LF transmission. We compared the effectiveness of two survey designs for post-MDA surveillance: a school-based survey of children aged 6-7 years, and a community-based survey targeting people aged ≥8 years.

Methods: In 2016, we conducted a systematic school-based TAS in all elementary schools (N = 29) and a cluster survey in 28 villages on the two main islands of American Samoa. We collected information on demographics and risk factors for infection using electronic questionnaires, and recorded geo-locations of schools and households. Blood samples were collected to test for circulating filarial antigen (CFA) using the Alere Filariasis Test Strip. For those who tested positive, we prepared slides for microscopic examination of microfilaria and provided treatment. Descriptive statistics were performed for questionnaire variables. Data were weighted and adjusted to account for sampling design and sex for both surveys, and for age in the community survey.

Results: The school-based TAS (n = 1143) identified nine antigen-positive children and found an overall adjusted CFA prevalence of 0.7% (95% CI: 0.3-1.8). Of the nine positive children, we identified one microfilariaemic 7-year-old child. The community-based survey (n = 2507, 711 households) identified 102 antigen-positive people, and estimated an overall adjusted CFA prevalence of 6.2% (95% CI: 4.5-8.6). Adjusted village-level prevalence ranged from 0-47.1%. CFA prevalence increased with age and was higher in males. Of 86 antigen-positive community members from whom slides were prepared, 22 (25.6%) were microfilaraemic. School-based TAS had limited sensitivity (range 0-23.8%) and negative predictive value (range 25-83.3%) but had high specificity (range 83.3-100%) and positive predictive value (range 0-100%) for identifying villages with ongoing transmission.

Conclusions: American Samoa failed the school-based TAS in 2016, and the community-based survey identified higher than expected numbers of antigen-positive people. School-based TAS was logistically simpler and enabled sampling of a larger proportion of the target population, but the results did not provide a good indication of the overall CFA prevalence in older age groups and was not sensitive at identifying foci of ongoing transmission. The community-based survey, although operationally more challenging, identified antigen-positive individuals of all ages, and foci of high antigen prevalence. Both surveys confirmed recrudescence of LF transmission.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Sample village map used to identify selected households during fieldwork, American Samoa, 2016.
Fig 2
Fig 2. Blood film with microfilaria from infected study participant, American Samoa, 2016.
Fig 3
Fig 3. Age and sex distribution of participants (bars) from community survey and general population (dotted lines) living in American Samoa, 2016.
Population estimates based on American Samoa 2014 Statistical Yearbook (American Samoa Department of Commerce).
Fig 4
Fig 4
Adjusted* circulating filarial antigen (CFA) prevalence with 95% CIs [A] and microfilaraemic individuals by age and sex in community survey [B], American Samoa 2016. *Adjusted for survey design.
Fig 5
Fig 5. Location of selected villages (N = 28) and adjusted* circulating filarial antigen (CFA) prevalence, American Samoa, 2016.
*Adjusted for survey design, age and sex distribution of American Samoa. To illustrate the distribution of the general population across American Samoa, locations of households (grey dots) are also shown.

Similar articles

Cited by

References

    1. Ramaiah KD, Ottesen EA. Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease. PLoS Negl Trop Dis. 2014;8(11):e3319 10.1371/journal.pntd.0003319 ; PubMed Central PMCID: PMC4239120. - DOI - PMC - PubMed
    1. World Health Organization. Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. 2011.
    1. World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2015. Weekly epidemiological record,. 2016;91(39):441–60. - PubMed
    1. Ichimori K, Graves PM. Overview of PacELF-the Pacific Programme for the Elimination of Lymphatic Filariasis. Tropical medicine and health. 2017;45:34 10.1186/s41182-017-0075-4 ; PubMed Central PMCID: PMCPMC5664808. - DOI - PMC - PubMed
    1. WHO Western Pacific Region. Congratulations, Tonga! Pacific island state eliminates lymphatic filariasis as a public health problem World Health Organization2017 [7 September 2017]. Available from: http://www.wpro.who.int/mediacentre/releases/2017/20170731/en/.

Publication types

MeSH terms

Grants and funding

This work received financial support from the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD), which is funded at The Task Force for Global Health primarily by the Bill & Melinda Gates Foundation, the United Kingdom Department for International Development, and by the United States Agency for International Development through its Neglected Tropical Diseases Program. MS was supported by scholarships from the Australian Government Research Training Program and the National Centre for Immunisation Research and Surveillance, Australia. CLL holds an Australian National Health and Medical Research Council Fellowship (1109035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

LinkOut - more resources